Dr. Clint Cary’s research efforts focus on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder, and prostate cancer. He has a study in progress to assess utilization rates of single dose intravesical chemotherapy in patients with non-muscle invasive bladder cancer in a population-based environment.
He actively publishes on advanced testicular cancer outcomes in numerous high-impact journals and has authored numerous book chapters on the topic of testicular cancer. He has served as a Visiting Professor both nationally and internationally to disseminate his research findings.
He provides direct medical and surgical care, with a specific focus on patients with testicular cancer and bladder cancer.
Dr. Cary serves as the Director of Urologic Oncology Research for the Department of Urology, a member of the American Urological Association (AUA) Young Urologists Committee, and AUA Liaison to the Young Physician Section of AMA House of Delegates.